TORONTO – Today, the Canadian Medical Cannabis Council (CMCC) welcomes the Canadian Hospice Palliative Care Association (CHPCA) as the newest member of the medical cannabis industry’s first Patient Advisory Committee (PAC). The Committee, made up of leading patient groups from across Canada, works to ensure patients and their best interests are the focus of the practices, activities and policy advocacy of CMCC.
“The Canadian Hospice Palliative Care Association is a tremendous addition to the Patient Advisory Council,” says Philippe Lucas, CMCC’s Interim Executive Director. “The group offers the medical cannabis industry a valuable perspective related to ethical, compassionate end-of-life care that puts patients’ best interests first.”
The Canadian Hospice Palliative Care Association is dedicated to the pursuit of excellence in care for persons approaching death. The CHPCA operates in close partnership with other national organizations and continues to work to ensure that all Canadians, regardless of where they may live, have equal access to quality hospice palliative care services for themselves and their families.
According to the World Health Organization, only one in ten people needing palliative care is currently receiving it. “Adequate pain control is a crucial element of effective palliative care,” said Sharon Baxter, Executive Director for the Canadian Hospice Palliative Care Association. ”We believe that by joining CMCC, we add another important patient voice to the discussion surrounding medical cannabis, and how it fits the needs of hospice patients.”
About the Canadian Hospice Palliative Care Association
The Canadian Hospice Palliative Care Association is the national association representing hospice palliative care and currently has approximately 3,000 members who represent all provincial hospice palliative care associations as well as the various professional, volunteer, and specialty groups involved in end-of-life care across the country. This includes those who are involved in shaping and implementing clinical practice and policy. Its work includes public and health policy, education and awareness.
Established in 1991, its volunteer Board of Directors is composed of hospice palliative care workers and volunteers from Canadian provinces as well as members-at-large.
About the Canadian Medical Cannabis Council (CMCC)
The Canadian Medical Cannabis Council is an industry group representing stakeholders who are committed to advancing the highest standards of integrity, safety, quality, access, security and research within Canada’s medical cannabis industry. All CMCC members are required to adhere to a Code of Ethics designed to serve patients’ best interests.
For more information, or to speak with a representative of CMCC, please contact:
416.425.9143 x11 or 1.866.337.3362 x11